Literature DB >> 816400

Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions.

D C Dale, H Y Reynolds, J E Pennington, R J Elin, G P Herzig.   

Abstract

Pseudomonas aeruginosa pneumonia was produced in dogs with radiation-induced leukopenia to study the comparative efficacy of several different therapies. In a randomized control trial, five treatment regimens were compared: no antibiotics or granulocytes (controls), gentamicin (5 mg/kg/day), carbenicillin (500 mg/kg/day), gentamicin and carbenicillin (same dosages), and daily granulocyte transfusion (minimum 5 x 10(9) cells/day) plus gentamicin (5 mg/kg/day). The most effective therapy was gentamicin plus granulocyte transfusions. Gentamicin alone was not significantly better than no specific therapy. Carbenicillin with or without gentamicin gave intermediate results. This study further supports the utility of granulocyte replacement therapy of infections in severely granulocytopenic subjects. The results also indicate that the relative value of granulocyte transfusions depends upon the specific antibiotic regimen with which these transfusions are compared.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816400

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Granulocyte transfusion: questions remain.

Authors:  Jose A Cancelas
Journal:  Blood       Date:  2015-10-29       Impact factor: 22.113

2.  Quantitative determination of the effect of granulocytes on the course of experimental infections during antibiotic treatment.

Authors:  G B van der Voet; H Mattie; R van Furth
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

Review 3.  Scope and limitations of experimental chemotherapy.

Authors:  O Zak
Journal:  Experientia       Date:  1980-04-15

Review 4.  Granulocyte transfusions in the management of invasive fungal infections.

Authors:  Kamille A West; Juan Gea-Banacloche; David Stroncek; Sameer S Kadri
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

5.  Protection of immunosuppressed mice against infection with pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein OprI.

Authors:  R Rahner; A Eckhardt; M Duchêne; H Domdey; B U von Specht
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

6.  Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.

Authors:  M W Kunst; H Mattie; R van Furth
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  Comparison of serum bactericidal activity among three antimicrobial combinations.

Authors:  J Murillo; H C Standiford; S C Schimpff; B A Tatem
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Neutrophils Derived from Genetically Modified Human Induced Pluripotent Stem Cells Circulate and Phagocytose Bacteria In Vivo.

Authors:  Lisa R Trump; Ramesh C Nayak; Abhishek K Singh; Sana Emberesh; Ashley M Wellendorf; Carolyn M Lutzko; Jose A Cancelas
Journal:  Stem Cells Transl Med       Date:  2019-02-21       Impact factor: 6.940

Review 10.  Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.

Authors:  Lise J Estcourt; Simon J Stanworth; Sally Hopewell; Carolyn Doree; Marialena Trivella; Edwin Massey
Journal:  Cochrane Database Syst Rev       Date:  2016-04-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.